Physician

Suparna Rudrapatna Krishnaiengar, MD

According to 2025 Medicare claims, Suparna Krishnaiengar, MD (NPI: 1225178619) practices epileptologists in the Jacksonville, FL market, with the plurality of this provider's patient population coming from Duval, FL. This provider's primary affiliated billing organization is UNIVERSITY OF FLORIDA JACKSONVILLE PHYSICIANS, INC. (NPI: 1104085752) and primary practice location at 32209-6511. Krishnaiengar is affiliated with the UF HEALTH ACO JACKSONVILLE, LLC (ACO ID: A5465), participating under the MSSP model.

Krishnaiengar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 191 traditional Medicare patients, billed 316 HCPCS/CPT codes, and received $24,569 in Medicare payments. The top billing code was 95720 (Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional). Part D data shows 1,129 prescription claims across 144 beneficiaries totaling $354,673 in drug costs, led by Aptiom (Eslicarbazepine Acetate). 2017 DME data shows 13 claims. Open Payments data shows 6 records totaling $19,238. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $60,016 to $24,569. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	509	815	$60,016
2016	489	827	$59,725
2017	437	729	$53,251
2018	423	772	$66,642
2019	433	702	$60,955
2020	299	459	$37,241
2021	311	471	$37,810
2022	297	430	$35,599
2023	229	367	$32,441
2024	191	316	$24,569

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	241	1,932	$393,707
2016	238	2,056	$407,388
2017	225	1,943	$501,432
2018	206	1,485	$420,396
2019	228	1,749	$480,892
2020	194	1,528	$461,059
2021	195	1,471	$529,216
2022	161	1,304	$383,665
2023	184	1,167	$397,331
2024	144	1,129	$354,673

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	13	$324
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95720	Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional	31	55	$160
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	26	29	$85
95822	Measurement of brain wave activity (eeg), in coma or asleep	51	52	$43
95816	Measurement of brain wave activity (eeg), awake and drowsy	29	29	$39
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	20	23	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Aptiom	Eslicarbazepine Acetate	35	1,326	$85,405
Epidiolex	Cannabidiol (Cbd)	35	1,059	$75,123
Xcopri	Cenobamate	22	640	$23,537
Nurtec Odt	Rimegepant Sulfate	12	383	$22,271
Emgality Pen	Galcanezumab-Gnlm	20	660	$14,954

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	6	$19,238	UCB SA
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Suparna Rudrapatna Krishnaiengar, MD?

Tedicare shows public-source Medicare data for Suparna Rudrapatna Krishnaiengar, MD (NPI 1225178619), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Suparna Rudrapatna Krishnaiengar, MD have ACO affiliation data?

Suparna Rudrapatna Krishnaiengar, MD is shown with ACO affiliation data for UF HEALTH ACO JACKSONVILLE, LLC (MSSP, ACO ID A5465).

What billing organization is linked to Suparna Rudrapatna Krishnaiengar, MD?

Suparna Rudrapatna Krishnaiengar, MD is linked to UNIVERSITY OF FLORIDA JACKSONVILLE PHYSICIANS, INC. (billing NPI 1104085752) in the available physician profile data.

Does Suparna Rudrapatna Krishnaiengar, MD have Open Payments data?

Suparna Rudrapatna Krishnaiengar, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.